CYTE Global
Gloria Kayani serves as the Chief Executive Officer at CYTE Global since January 2018. Prior to this role, Gloria held the position of Chief Operating Officer/Deputy Director at Thrombosis Research Institute in London from October 2012 to January 2024, where operational responsibilities included the implementation and delivery of extensive clinical and scientific research programs. From July 2002 to September 2012, Gloria was the Head of Clinical Projects Group at Roche Pharmaceuticals, overseeing UK Clinical Operations and managing a team of 51 staff in various clinical trial initiatives. Gloria's career at Roche also included several leadership roles in Pharma Development Clinical Operations and Data Management. Beginning career at GSK in September 1998, Gloria worked as a Line Manager in the Data Management Team and as a Clinical Data Manager until July 2002.
This person is not in any teams
This person is not in any offices
CYTE Global
CYTE is a unique CRO powered by a global network of over 3,000 sites in 45 countries. Our online platform enables seamless collaboration between sites, sponsors, and study management. We also offer a suite of support services such as data analytics and medical writing to ensure your study gets across the line. CYTE was established as the delivery arm of the Thrombosis Research Institute (TRI) in London. TRI has been conducting scientific, clinical and outcomes research in cardiovascular disease for over 30 years. CYTE now delivers these world-leading capabilities in partnership with sponsors around the world.